Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or BothMarc A. Pfeffer, Robert M. Califf, Susan Edwards et al.|New England Journal of Medicine|2003Cited by 2.5k
Dabigatran versus Warfarin in Patients with Mechanical Heart ValvesJohn W. Eikelboom, Frans Van de Werf, Stuart J. Connolly et al.|New England Journal of Medicine|2013Cited by 1.5k
Relationship of TIMI Myocardial Perfusion Grade to Mortality After Administration of Thrombolytic DrugsC. Michael Gibson, Eugene Braunwald, Christopher P. Cannon et al.|Circulation|2000Cited by 856
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary SyndromesPierluigi Tricoci, Kenneth W. Mahaffey, Zhen Huang et al.|New England Journal of Medicine|2011Cited by 753
Impact of Bleeding Severity on Clinical Outcomes Among Patients With Acute Coronary SyndromesSunil V. Rao, Robert A. Harrington, Kristi O’Grady et al.|The American Journal of Cardiology|2005Cited by 632